المؤشر الحيوي للسرطان (Arabic Wikipedia)

Analysis of information sources in references of the Wikipedia article "المؤشر الحيوي للسرطان" in Arabic language version.

refsWebsite

Global rank Arabic rank

24nih.gov

4^th place

6^th place

18doi.org

2^nd place

5^th place

4web.archive.org

1^st place

3worldcat.org

5^th place

4^th place

2archive.org

6^th place

3^rd place

1mlo-online.com

low place

1zenodo.org

621^st place

1,331^st place

1sciencedirect.com

149^th place

233^rd place

1cancer.gov

1,684^th place

1,025^th place

archive.org

Calzone، Kathleen A. (2012). "Genetic Biomarkers of Cancer Risk". Seminars in Oncology Nursing. ج. 28 ع. 2: 122–128. DOI:10.1016/j.soncn.2012.03.007. PMID:22542320.
Leong، PP؛ Rezai, B؛ Koch, WM؛ Reed, A؛ Eisele, D؛ Lee, DJ؛ Sidransky, D؛ Jen, J؛ Westra, WH (1 يوليو 1998). "Distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma". Journal of the National Cancer Institute. ج. 90 ع. 13: 972–7. DOI:10.1093/jnci/90.13.972. PMID:9665144.

cancer.gov

"biomarker". NCI Dictionary of Cancer Terms. National Cancer Institute. 2 فبراير 2011. مؤرشف من الأصل في 2020-05-09.

doi.org

Calzone، Kathleen A. (2012). "Genetic Biomarkers of Cancer Risk". Seminars in Oncology Nursing. ج. 28 ع. 2: 122–128. DOI:10.1016/j.soncn.2012.03.007. PMID:22542320.
Herceg, Zdenko; Hainaut, Pierre (1 Jun 2007). "Genetic and epigenetic alterations as biomarkers for cancer detection, diagnosis and prognosis". Molecular Oncology (بالإنجليزية). 1 (1): 26–41. DOI:10.1016/j.molonc.2007.01.004. ISSN:1878-0261. PMC:5543860. PMID:19383285.
Li، Danni؛ Chan، Daniel W. (1 أبريل 2014). "Proteomic cancer biomarkers from discovery to approval: it's worth the effort". Expert Review of Proteomics. ج. 11 ع. 2: 135–136. DOI:10.1586/14789450.2014.897614. ISSN:1478-9450. PMC:4079106. PMID:24646122.
Aizpurua-Olaizola، O.؛ Toraño، J. Sastre؛ Falcon-Perez، J.M.؛ Williams، C.؛ Reichardt، N.؛ Boons، G.-J. (2018). "Mass spectrometry for glycan biomarker discovery". TrAC Trends in Analytical Chemistry. ج. 100: 7–14. DOI:10.1016/j.trac.2017.12.015.
Mishra، Alok؛ Verma, Mukesh (2010). "Cancer Biomarkers: Are We Ready for the Prime Time?". Cancers. ج. 2 ع. 1: 190–208. DOI:10.3390/cancers2010190. PMC:3827599. PMID:24281040.{{استشهاد بدورية محكمة}}: صيانة الاستشهاد: دوي مجاني غير معلم (link)
Behne، Tara؛ Copur, M. Sitki (1 يناير 2012). "Biomarkers for Hepatocellular Carcinoma". International Journal of Hepatology. ج. 2012: 859076. DOI:10.1155/2012/859076. PMC:3357951. PMID:22655201.{{استشهاد بدورية محكمة}}: صيانة الاستشهاد: دوي مجاني غير معلم (link)
Musolino، A؛ Bella, MA؛ Bortesi, B؛ Michiara, M؛ Naldi, N؛ Zanelli, P؛ Capelletti, M؛ Pezzuolo, D؛ Camisa, R؛ Savi, M؛ Neri, TM؛ Ardizzoni, A (يونيو 2007). "BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: a population-based study". Breast. ج. 16 ع. 3: 280–92. DOI:10.1016/j.breast.2006.12.003. PMID:17257844.
Dienstmann، R؛ Tabernero, J (مارس 2011). "BRAF as a target for cancer therapy". Anti-Cancer Agents in Medicinal Chemistry. ج. 11 ع. 3: 285–95. DOI:10.2174/187152011795347469. PMID:21426297.
Lamparella، N؛ Barochia, A؛ Almokadem, S (2013). Impact of genetic markers on treatment of non-small cell lung cancer. ج. 779. ص. 145–64. DOI:10.1007/978-1-4614-6176-0_6. ISBN:978-1-4614-6175-3. PMID:23288638. {{استشهاد بكتاب}}: |صحيفة= تُجوهل (مساعدة)
Orphanos، G؛ Kountourakis, P (2012). "Targeting the HER2 receptor in metastatic breast cancer". Hematology/Oncology and Stem Cell Therapy. ج. 5 ع. 3: 127–37. DOI:10.5144/1658-3876.2012.127. PMID:23095788.
DePrimo، S. E.؛ Huang, X.؛ Blackstein, M. E.؛ Garrett, C. R.؛ Harmon, C. S.؛ Schoffski, P.؛ Shah, M. H.؛ Verweij, J.؛ Baum, C. M.؛ Demetri, G. D. (8 سبتمبر 2009). "Circulating Levels of Soluble KIT Serve as a Biomarker for Clinical Outcome in Gastrointestinal Stromal Tumor Patients Receiving Sunitinib following Imatinib Failure". Clinical Cancer Research. ج. 15 ع. 18: 5869–5877. DOI:10.1158/1078-0432.CCR-08-2480. PMC:3500590. PMID:19737953.
Kruijff، S؛ Hoekstra, HJ (أبريل 2012). "The current status of S-100B as a biomarker in melanoma". European Journal of Surgical Oncology. ج. 38 ع. 4: 281–5. DOI:10.1016/j.ejso.2011.12.005. PMID:22240030.
Ludwig، JA؛ Weinstein, JN (نوفمبر 2005). "Biomarkers in cancer staging, prognosis and treatment selection". Nature Reviews Cancer. ج. 5 ع. 11: 845–56. DOI:10.1038/nrc1739. PMID:16239904. مؤرشف من الأصل في 2020-05-09.
Wang، Qing؛ Raghothama Chaerkady (ديسمبر 2010). "Mutant proteins as cancer-specific biomarkers". Proceedings of the National Academy of Sciences. ج. 108 ع. 6: 2444–2449. DOI:10.1073/pnas.1019203108. PMC:3038743. PMID:21248225.
Li, Xuanying; Ye, Mengsha; Zhang, Weiying; Tan, Duo; Jaffrezic-Renault, Nicole; Yang, Xu; Guo, Zhenzhong (1 Feb 2019). "Liquid biopsy of circulating tumor DNA and biosensor applications". Biosensors and Bioelectronics (بالإنجليزية). 126: 596–607. DOI:10.1016/j.bios.2018.11.037. ISSN:0956-5663. PMID:30502682. Archived from the original on 2020-05-09.
Verma، M؛ Manne, U (أكتوبر 2006). "Genetic and epigenetic biomarkers in cancer diagnosis and identifying high risk populations". Critical Reviews in Oncology/Hematology. ج. 60 ع. 1: 9–18. DOI:10.1016/j.critrevonc.2006.04.002. PMID:16829121.
Leong، PP؛ Rezai, B؛ Koch, WM؛ Reed, A؛ Eisele, D؛ Lee, DJ؛ Sidransky, D؛ Jen, J؛ Westra, WH (1 يوليو 1998). "Distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma". Journal of the National Cancer Institute. ج. 90 ع. 13: 972–7. DOI:10.1093/jnci/90.13.972. PMID:9665144.
Dragani، TA؛ Matarese, V؛ Colombo, F (2020). "Biomarkers for Early Cancer Diagnosis: Prospects for Success through the Lens of Tumor Genetics". BioEssays. ج. 42 ع. 4: e1900122. DOI:10.1002/bies.201900122. PMID:32128843.

mlo-online.com

Rhea، Jeanne؛ Ross J. Molinaro (مارس 2011). "Cancer Biomarkers: Surviving the journey from bench to bedside". Medical Laboratory Observer. مؤرشف من الأصل في 2013-10-14. اطلع عليه بتاريخ 2013-04-26.

nih.gov

pubmed.ncbi.nlm.nih.gov

Calzone، Kathleen A. (2012). "Genetic Biomarkers of Cancer Risk". Seminars in Oncology Nursing. ج. 28 ع. 2: 122–128. DOI:10.1016/j.soncn.2012.03.007. PMID:22542320.
Herceg, Zdenko; Hainaut, Pierre (1 Jun 2007). "Genetic and epigenetic alterations as biomarkers for cancer detection, diagnosis and prognosis". Molecular Oncology (بالإنجليزية). 1 (1): 26–41. DOI:10.1016/j.molonc.2007.01.004. ISSN:1878-0261. PMC:5543860. PMID:19383285.
Li، Danni؛ Chan، Daniel W. (1 أبريل 2014). "Proteomic cancer biomarkers from discovery to approval: it's worth the effort". Expert Review of Proteomics. ج. 11 ع. 2: 135–136. DOI:10.1586/14789450.2014.897614. ISSN:1478-9450. PMC:4079106. PMID:24646122.
Mishra، Alok؛ Verma, Mukesh (2010). "Cancer Biomarkers: Are We Ready for the Prime Time?". Cancers. ج. 2 ع. 1: 190–208. DOI:10.3390/cancers2010190. PMC:3827599. PMID:24281040.{{استشهاد بدورية محكمة}}: صيانة الاستشهاد: دوي مجاني غير معلم (link)
Behne، Tara؛ Copur, M. Sitki (1 يناير 2012). "Biomarkers for Hepatocellular Carcinoma". International Journal of Hepatology. ج. 2012: 859076. DOI:10.1155/2012/859076. PMC:3357951. PMID:22655201.{{استشهاد بدورية محكمة}}: صيانة الاستشهاد: دوي مجاني غير معلم (link)
Musolino، A؛ Bella, MA؛ Bortesi, B؛ Michiara, M؛ Naldi, N؛ Zanelli, P؛ Capelletti, M؛ Pezzuolo, D؛ Camisa, R؛ Savi, M؛ Neri, TM؛ Ardizzoni, A (يونيو 2007). "BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: a population-based study". Breast. ج. 16 ع. 3: 280–92. DOI:10.1016/j.breast.2006.12.003. PMID:17257844.
Dienstmann، R؛ Tabernero, J (مارس 2011). "BRAF as a target for cancer therapy". Anti-Cancer Agents in Medicinal Chemistry. ج. 11 ع. 3: 285–95. DOI:10.2174/187152011795347469. PMID:21426297.
Lamparella، N؛ Barochia, A؛ Almokadem, S (2013). Impact of genetic markers on treatment of non-small cell lung cancer. ج. 779. ص. 145–64. DOI:10.1007/978-1-4614-6176-0_6. ISBN:978-1-4614-6175-3. PMID:23288638. {{استشهاد بكتاب}}: |صحيفة= تُجوهل (مساعدة)
Orphanos، G؛ Kountourakis, P (2012). "Targeting the HER2 receptor in metastatic breast cancer". Hematology/Oncology and Stem Cell Therapy. ج. 5 ع. 3: 127–37. DOI:10.5144/1658-3876.2012.127. PMID:23095788.
DePrimo، S. E.؛ Huang, X.؛ Blackstein, M. E.؛ Garrett, C. R.؛ Harmon, C. S.؛ Schoffski, P.؛ Shah, M. H.؛ Verweij, J.؛ Baum, C. M.؛ Demetri, G. D. (8 سبتمبر 2009). "Circulating Levels of Soluble KIT Serve as a Biomarker for Clinical Outcome in Gastrointestinal Stromal Tumor Patients Receiving Sunitinib following Imatinib Failure". Clinical Cancer Research. ج. 15 ع. 18: 5869–5877. DOI:10.1158/1078-0432.CCR-08-2480. PMC:3500590. PMID:19737953.
Bantis، A؛ Grammaticos, P (سبتمبر–ديسمبر 2012). "Prostatic specific antigen and bone scan in the diagnosis and follow-up of prostate cancer. Can diagnostic significance of PSA be increased?". Hellenic Journal of Nuclear Medicine. ج. 15 ع. 3: 241–6. PMID:23227460.
Kruijff، S؛ Hoekstra, HJ (أبريل 2012). "The current status of S-100B as a biomarker in melanoma". European Journal of Surgical Oncology. ج. 38 ع. 4: 281–5. DOI:10.1016/j.ejso.2011.12.005. PMID:22240030.
Ludwig، JA؛ Weinstein, JN (نوفمبر 2005). "Biomarkers in cancer staging, prognosis and treatment selection". Nature Reviews Cancer. ج. 5 ع. 11: 845–56. DOI:10.1038/nrc1739. PMID:16239904. مؤرشف من الأصل في 2020-05-09.
Wang، Qing؛ Raghothama Chaerkady (ديسمبر 2010). "Mutant proteins as cancer-specific biomarkers". Proceedings of the National Academy of Sciences. ج. 108 ع. 6: 2444–2449. DOI:10.1073/pnas.1019203108. PMC:3038743. PMID:21248225.
Li, Xuanying; Ye, Mengsha; Zhang, Weiying; Tan, Duo; Jaffrezic-Renault, Nicole; Yang, Xu; Guo, Zhenzhong (1 Feb 2019). "Liquid biopsy of circulating tumor DNA and biosensor applications". Biosensors and Bioelectronics (بالإنجليزية). 126: 596–607. DOI:10.1016/j.bios.2018.11.037. ISSN:0956-5663. PMID:30502682. Archived from the original on 2020-05-09.
Verma، M؛ Manne, U (أكتوبر 2006). "Genetic and epigenetic biomarkers in cancer diagnosis and identifying high risk populations". Critical Reviews in Oncology/Hematology. ج. 60 ع. 1: 9–18. DOI:10.1016/j.critrevonc.2006.04.002. PMID:16829121.
Leong، PP؛ Rezai, B؛ Koch, WM؛ Reed, A؛ Eisele, D؛ Lee, DJ؛ Sidransky, D؛ Jen, J؛ Westra, WH (1 يوليو 1998). "Distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma". Journal of the National Cancer Institute. ج. 90 ع. 13: 972–7. DOI:10.1093/jnci/90.13.972. PMID:9665144.
Dragani، TA؛ Matarese, V؛ Colombo, F (2020). "Biomarkers for Early Cancer Diagnosis: Prospects for Success through the Lens of Tumor Genetics". BioEssays. ج. 42 ع. 4: e1900122. DOI:10.1002/bies.201900122. PMID:32128843.

ncbi.nlm.nih.gov

Herceg, Zdenko; Hainaut, Pierre (1 Jun 2007). "Genetic and epigenetic alterations as biomarkers for cancer detection, diagnosis and prognosis". Molecular Oncology (بالإنجليزية). 1 (1): 26–41. DOI:10.1016/j.molonc.2007.01.004. ISSN:1878-0261. PMC:5543860. PMID:19383285.
Li، Danni؛ Chan، Daniel W. (1 أبريل 2014). "Proteomic cancer biomarkers from discovery to approval: it's worth the effort". Expert Review of Proteomics. ج. 11 ع. 2: 135–136. DOI:10.1586/14789450.2014.897614. ISSN:1478-9450. PMC:4079106. PMID:24646122.
Mishra، Alok؛ Verma, Mukesh (2010). "Cancer Biomarkers: Are We Ready for the Prime Time?". Cancers. ج. 2 ع. 1: 190–208. DOI:10.3390/cancers2010190. PMC:3827599. PMID:24281040.{{استشهاد بدورية محكمة}}: صيانة الاستشهاد: دوي مجاني غير معلم (link)
Behne، Tara؛ Copur, M. Sitki (1 يناير 2012). "Biomarkers for Hepatocellular Carcinoma". International Journal of Hepatology. ج. 2012: 859076. DOI:10.1155/2012/859076. PMC:3357951. PMID:22655201.{{استشهاد بدورية محكمة}}: صيانة الاستشهاد: دوي مجاني غير معلم (link)
DePrimo، S. E.؛ Huang, X.؛ Blackstein, M. E.؛ Garrett, C. R.؛ Harmon, C. S.؛ Schoffski, P.؛ Shah, M. H.؛ Verweij, J.؛ Baum, C. M.؛ Demetri, G. D. (8 سبتمبر 2009). "Circulating Levels of Soluble KIT Serve as a Biomarker for Clinical Outcome in Gastrointestinal Stromal Tumor Patients Receiving Sunitinib following Imatinib Failure". Clinical Cancer Research. ج. 15 ع. 18: 5869–5877. DOI:10.1158/1078-0432.CCR-08-2480. PMC:3500590. PMID:19737953.
Wang، Qing؛ Raghothama Chaerkady (ديسمبر 2010). "Mutant proteins as cancer-specific biomarkers". Proceedings of the National Academy of Sciences. ج. 108 ع. 6: 2444–2449. DOI:10.1073/pnas.1019203108. PMC:3038743. PMID:21248225.

sciencedirect.com

Li, Xuanying; Ye, Mengsha; Zhang, Weiying; Tan, Duo; Jaffrezic-Renault, Nicole; Yang, Xu; Guo, Zhenzhong (1 Feb 2019). "Liquid biopsy of circulating tumor DNA and biosensor applications". Biosensors and Bioelectronics (بالإنجليزية). 126: 596–607. DOI:10.1016/j.bios.2018.11.037. ISSN:0956-5663. PMID:30502682. Archived from the original on 2020-05-09.

web.archive.org

Rhea، Jeanne؛ Ross J. Molinaro (مارس 2011). "Cancer Biomarkers: Surviving the journey from bench to bedside". Medical Laboratory Observer. مؤرشف من الأصل في 2013-10-14. اطلع عليه بتاريخ 2013-04-26.
Ludwig، JA؛ Weinstein, JN (نوفمبر 2005). "Biomarkers in cancer staging, prognosis and treatment selection". Nature Reviews Cancer. ج. 5 ع. 11: 845–56. DOI:10.1038/nrc1739. PMID:16239904. مؤرشف من الأصل في 2020-05-09.
Li, Xuanying; Ye, Mengsha; Zhang, Weiying; Tan, Duo; Jaffrezic-Renault, Nicole; Yang, Xu; Guo, Zhenzhong (1 Feb 2019). "Liquid biopsy of circulating tumor DNA and biosensor applications". Biosensors and Bioelectronics (بالإنجليزية). 126: 596–607. DOI:10.1016/j.bios.2018.11.037. ISSN:0956-5663. PMID:30502682. Archived from the original on 2020-05-09.
"biomarker". NCI Dictionary of Cancer Terms. National Cancer Institute. 2 فبراير 2011. مؤرشف من الأصل في 2020-05-09.

worldcat.org

Herceg, Zdenko; Hainaut, Pierre (1 Jun 2007). "Genetic and epigenetic alterations as biomarkers for cancer detection, diagnosis and prognosis". Molecular Oncology (بالإنجليزية). 1 (1): 26–41. DOI:10.1016/j.molonc.2007.01.004. ISSN:1878-0261. PMC:5543860. PMID:19383285.
Li، Danni؛ Chan، Daniel W. (1 أبريل 2014). "Proteomic cancer biomarkers from discovery to approval: it's worth the effort". Expert Review of Proteomics. ج. 11 ع. 2: 135–136. DOI:10.1586/14789450.2014.897614. ISSN:1478-9450. PMC:4079106. PMID:24646122.
Li, Xuanying; Ye, Mengsha; Zhang, Weiying; Tan, Duo; Jaffrezic-Renault, Nicole; Yang, Xu; Guo, Zhenzhong (1 Feb 2019). "Liquid biopsy of circulating tumor DNA and biosensor applications". Biosensors and Bioelectronics (بالإنجليزية). 126: 596–607. DOI:10.1016/j.bios.2018.11.037. ISSN:0956-5663. PMID:30502682. Archived from the original on 2020-05-09.

zenodo.org

Ludwig، JA؛ Weinstein, JN (نوفمبر 2005). "Biomarkers in cancer staging, prognosis and treatment selection". Nature Reviews Cancer. ج. 5 ع. 11: 845–56. DOI:10.1038/nrc1739. PMID:16239904. مؤرشف من الأصل في 2020-05-09.